| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
| Lantheus Holdings, Inc | $4.8b | $75.87 | -0.3% | 79.5K | |
| Immunome, Inc. | $2.2b | $22.20 | +1.6% | 145.0K | |
| AbCellera Biologics Inc. Common Shares | $1.0b | $3.50 | -0.4% | 769.8K | |
| Aktis Oncology, Inc. Common stock | $0.9b | $16.84 | -3.1% | 59.4K | |
| Alpha Tau Medical Ltd. Ordinary Shares | $0.6b | $6.97 | +0.7% | 98.0K | |
| Crescent Biopharma, Inc. Common Stock | $0.5b | $19.93 | +2.8% | 80.4K | |
| Perspective Therapeutics, Inc. | $436.4m | $4.53 | +2.7% | 183.0K | |
| PLUS THERAPEUTICS, Inc. Common Stock | $36.8m | $3.38 | -5.2% | 271.9K | |
| Actinium Pharmaceuticals, Inc | $30.9m | $1.12 | +14.3% | 181.7K | |
| American Shared Hospital Services | $11.9m | $1.33 | -1.4% | 19.9K | |
| iTonic Holdings Ltd Class A Ordinary Shares | $7.0m | $0.32 | +3.9% | 102.9K |